Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM4 | Q14833 | 14/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.35 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.32 |
| ▸ | HTR2B | P41595 | 1/20 | 0.32 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22735928 | 0.86 | GRM4 (0.33) | GRM4KCNH2EGLN1 | |
| SCHEMBL29480752 | 0.86 | GRM4 (0.33) | GRM4KCNH2EGLN1 | |
| SCHEMBL29480658 | 0.85 | GRM4 (0.34) | GRM4 | |
| SCHEMBL22735779 | 0.85 | GRM4 (0.34) | GRM4 | |
| SCHEMBL29480762 | 0.81 | MELK (0.38) | GRM4EGLN1 | |
| SCHEMBL22736011 | 0.81 | GRM4 (0.35) | GRM4KCNH2EGLN1 | |
| SCHEMBL29480656 | 0.81 | GRM4 (0.35) | GRM4KCNH2EGLN1 | |
| SCHEMBL29567639 | 0.79 | GRM4 (0.32) | GRM4EGLN1 | |
| SCHEMBL22736041 | 0.79 | GRM4 (0.32) | GRM4EGLN1 | |
| SCHEMBL22736069 | 0.79 | GRM4 (0.33) | GRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12516056-B2 | Compounds for inhibition of janus kinase 1 | MANKIND PHARMA LTD. (IN) | 2026-01-06 | — | — | US | disclosed |
| EP-3976612-A1 | NOVEL COMPOUNDS FOR INHIBITION OF JANUS KINASE 1 | MANKIND PHARMA LTD (IN) | 2022-04-06 | — | — | EP | disclosed |
| CN-114174294-A | Novel compounds for inhibiting JANUS kinase 1 | 人类制药有限公司 | 2022-03-11 | — | — | CN | disclosed |